stars 1 stars 2 stars 3

Flexion Therapeutics (NASDAQ: FLXN) is a biopharmaceutical company focused on the discovery, development & commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions. Flexion is based in Burlington, Massachusetts. View our terms of use: https://flexiontherapeutics.com/terms-of-use/

Flexion Therapeutics Questions

The Flexion Therapeutics annual revenue was $33.5 million in 2026.

Melissa Layman is the Chief Commercial Officer of Flexion Therapeutics.

22 people are employed at Flexion Therapeutics.

Flexion Therapeutics is based in Burlington, Massachusetts.

The NAICS codes for Flexion Therapeutics are [32541, 3254, 325414, 325413, 32, 325].

The SIC codes for Flexion Therapeutics are [283, 28].

Top Flexion Therapeutics Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users